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Disruption of mouse polymerase ζ (Rev3) leads to embryonic
lethality and impairs blastocyst development in vitro
Mats Bemark*, Amine A. Khamlichi*†, Sarah L. Davies*
and Michael S. Neuberger*
Multiple DNA polymerases exist in eukaryotes.
Polymerases α, δ and ε are mainly responsible for
chromosomal DNA replication in the nucleus and are
required for proliferation. In contrast, the repair
polymerases β and η are not essential for cellular
proliferation in yeast or mice, but a lack of either
polymerase can lead, respectively, to defects in base
excision repair or the ability to replicate past lesions
induced by ultraviolet (UV) radiation [1–3]. Here, we
have focused on polymerase ζ. This was first described
as a non-essential product of the yeast REV3/REV7
genes involved in UV-induced mutagenesis, and was
later implicated in trans-lesion synthesis [4,5]. Unlike in
yeast, the mouse homologue (mRev3) was found to be
essential for life. Homozygous mutant mice died
in utero. Mutant embryos were considerably reduced in
size at day 10.5 of development and usually aborted
around day 12.5. It is likely that this block reflects a need
for mRev3 in proliferative clonal expansion (rather than
in the production of a particular cell type) as mutant
blastocysts showed greatly diminished expansion of the
inner cell mass in culture. Thus, mRev3 could be
required to repair a form of externally induced DNA
damage that otherwise accumulates during clonal
expansion or, consistent with the high homology shared
between its Rev7 partner and the mitotic checkpoint
gene product Mad2 [6], mRev3 might play a role in cell
proliferation and genomic stability even in the absence
of environmentally induced damage.
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Results and discussion
Gene targeting in embryonic stem (ES) cells was used to
study the function of mRev3, the murine homologue of
the catalytic subunit of yeast polymerase ζ. A targeting
construct was created in which a neomycin-resistance cas-
sette was inserted into the mRev3 gene in an exon that
encodes part of the carboxy-terminal portion of the poly-
merase. This targeting disrupts a region of the gene that is
highly conserved between yeast and mammals and flanks
the consensus polymerase motifs. Two ES cell lines were
obtained in which the neomycin cassette had recombined
into the endogenous mRev3 locus and one of these lines
was injected into blastocysts in order to establish chimaeric
mice for germ-line transmission of the targeted mRev3
allele (mRev3N; Figure 1). Crossing of mRev3+/mRev3N het-
erozygous mice failed to generate any homozygous mutant
animals. All the mice born were either heterozygous or
wild-type homozygotes at the mRev3 locus (Table 1). The
viability of the mRev3+/mRev3N heterozygotes indicates
that the mRev3 gene targeting does not itself yield a toxic
modified mRev3 gene product (or indeed a haploinsuffi-
ciency) that is incompatible with viability. Rather, normal
foetal development must be critically dependent on the
presence of a wild-type mRev3 allele 
Analysis of the foetuses produced on crossing mRev3N/mRev3+
heterozygotes revealed that mRev3N/mRev3N mutant
embryos were obtained at the expected frequency at
day 10.5 but were about 50% the length (and about one-
tenth the mass) of their wild-type or heterozygous coun-
terparts (Table 1; Figure 2a). By day 12.5, the frequency
of homozygous mutant embryos was significantly reduced,
probably because of resorption (Table 1). The most
obvious defect of the day 10.5 mRev3 mutant blastocysts
was their small size (as opposed to any other gross specific
anatomical abnormality) although, by day 12.5, deficien-
cies such as lack of pigmentation in the eye were evident. 
That the lethality of mRev3 disruption does not simply
reflect an essential function for mRev3 within only a
narrow cell lineage is strongly supported by the fact that
an effect of the gene disruption could be discerned in
blastocyst culture. Blastocysts were harvested at day 3.5
and cultured in vitro: they were observed on a daily basis
for 6 days before DNA extraction and typing by PCR
(Figure 2). In the case of blastocysts derived from control
mRev3+/mRev3+ breedings, blastocysts (in all but one case)
hatched between 2 and 4 days in culture, with the cells
attaching to the surface of the plate and exhibiting a typical
fried-egg appearance with a layer of giant trophoblast cells
surrounding the inner cell mass (ICM). The ICM then
proliferated vigorously over the next few days, forming a
large aggregate of cells (Figure 2b, top row).
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Figure 1
Targeting of mRev3. (a) Targeting strategy.
The structure of the mRev3 cDNA (originally
cloned as the stress-induced transcript Sez4
[13,14]) is shown at the top. Box, coding
sequence; dark and light grey, regions of high
and low homology, respectively, with yeast
REV3; roman numerals, the different
polymerase motifs. An mRev3 cDNA probe
was generated by PCR and used to isolate
mRev3 genomic clones from a mouse strain
129 λ phage library. A restriction map of part
of the wild-type mRev3 gene is shown. B,
Bgl II; R, EcoRI; S, SacI; X, XhoI. Bgl II sites
flanking the two depicted Bgl II sites are not
shown. A targeting vector was constructed in
which a neomycin-resistance cassette (neo)
was inserted into the XhoI site spanning
codons 2935–2937 with flanking homologies
of 2.3 kb and 1.8 kb in the left and right arms,
respectively. A thymidine kinase (TK )
cassette was included at the right hand side
of the targeting construct to permit
enrichment for homologously targeted
integrations. The source of the genomic
library and selection cassettes as well as the
procedures for ES cell transfection and
selection are as described previously [15,16].
The regions providing the 5′ and 3′ probes
used below and the positions of the PCR
primers P1, P2 and P3 are indicated.
(b) Identification of a targeted ES cell clone
by Southern blotting of genomic DNA. SacI-
digested DNA from ES cell transfectants G2,
G3 and G4 was hybridised with the 5′ mRev3
probe shown in (a). Two successful targeting
events were identified in the approximately
600 clones screened. WT, wild-type band.
(c) Germ-line transmission of the mRev3N
targeted allele was confirmed using either
the 5′ or 3′ mRev3 probes to hybridise to
Bgl II-digested tail DNA prepared from
offspring of a chimaeric founder male.
(d) PCR screening of DNA from mouse tails
and blastocysts using primers P1, P2 and
P3. Left panel, amplification of DNA prepared
from mouse tails, ES cells or targeting
plasmid stained with ethidium bromide. Right
panel, DNA amplified from blastocysts after
hybridising with a radiolabelled
oligonucleotide (5′-TTCAGCCTCAGAGTG-
GGATC-3′). DNA was prepared as described
in the legend to Figure 2 and the PCRs
performed using a 30-cycle program (95°C,
1 min; 55°C, 1 min; 72°C, 1 min) and a
mixture of all three primers (P1, 5′-CTTGCT-
TATGATCGGCGCTC-3′; P2, 5′-CAGCTG-
AAGACATCAATACC-3′; P3, 5′-GGACAT-
AGCGTTGGCTACCC-3′).
Current Biology   
(a)
(b) (c)
WT
neo
Sac I
5′ probe 5′ probe 3′ probe
Bgl II
(d)
Mice ES
P
la
sm
id Blastocyte
G2 G3 G4
WT
neo
+
+
N
+
+
+
N
+
N
+
N
+
+
+
N
+
N
N
WT
neo
S B X S B XS SRR R R RR R
1 kb
5′ 
probe
3′ 
probeP1 P2P3
Wild-type allele
Targeting vector
Targeted allele
S TKRRR
S B XS SR R RR R
mRev3 cDNA
IV II V
I III I V
S B RR
5′ 3′
neo
neo S
Table 1
Genotype of offspring and embryos from matings of Rev3-targeted mice.
Total
Number of number of Genotype of offspring
Breeding litters mice/embryos +/+ +/N N/N ND
Offspring
[+/+] x [+/N] 6 36 20 15 – 1
[+/N x [+/N] 21 164 64 96 0 4
Embryos
[+/N] x [+/N]
Day 10.5 4 42 Normal 13 15 0 1
Small 0 1 11 0
Reabsorbed 0 0 0 1
Day 12.5 4 41 Normal 13 17 0 0
Small 0 0 5 0
Reabsorbed 0 0 2* 4
*Two of the decidua contained parts of the yolk sac that could be typed by PCR. ND, not determined. Normal, normal-sized embryo; small, small
embryo (length < 75% of littermates); reabsorbed, reabsorbed embryo. 
In the case of blastocysts generated by crossing
mRev3+/mRev3N heterozygotes, four types of blastocyst
development could be distinguished by gross morphologi-
cal examination (Figure 2). Six of the 51 blastocysts did
not hatch at all and were not genotyped. Of the hatched
blastocysts, the majority (30/45) developed similarly to
those from the wild-type control breedings. These could
all be genotyped as either wild type or heterozygous for
the mRev3N mutation. Of the remainder, analysis at day 6
revealed either no obvious ICM (five examples) or an
ICM of much reduced size (ten examples). Genotyping
revealed that all five hatched blastocysts that failed to
develop any ICM as well as four of the blastocysts with a
small ICM were derived from mutant mRev3N homozy-
gotes. Thus, the mRev3 gene disruption has a prejudicial
effect on ICM expansion during in vitro blastocyst culture.
It is striking that mRev3 mutant blastocysts showed dimin-
ished expansion of the ICM when cultured and yet, in
vivo, mutant blastocysts could develop to generate mid-
gestation embryos, albeit of substantially reduced size.
Presumably, there are either environmental stresses
in vitro that make blastocyst development particularly
dependent on mRev3 or cues are provided in utero (or
developmental programmes followed) that render the
requirement for mRev3 less acute. Intriguing parallels to
this contrasting in vitro and in vivo development are pro-
vided by mice carrying mutations in Atm or Brca2. Atm–/–
mice are viable (though sterile, growth retarded and
immunologically and neurologically dysfunctional) but
embryonic fibroblasts obtained from Atm–/– mice fail to
grow under standard culture conditions [7–9]. Similarly,
foetuses of mice carrying a Brca2 truncation can survive to
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Figure 2
Phenotypes of embryos and cultured
blastocysts. (a) Phenotype of
mRev3N/mRev3N embryos at days 10.5 and
12.5 of development. Two examples from
each stage are shown together with wild-type
or heterozygous littermates for comparison.
The mRev3N/mRev3N embryos were 35–55%
the length of their normal littermates at day
10.5 and 25–60% of the normal length at
day 12.5. (b) Morphology of cultured
blastocysts. Examples are shown of normal
ICM, small ICM or no ICM at day 6 as well of
an untyped blastocyst that failed to hatch.
The cultures were visualised by phase-
contrast microscopy, and examples of the
distinction between ICM and trophoblast cells
(TC) indicated by arrowheads. The
blastocysts were taken at 3.5 days post
coitum and cultured in medium supplemented
with recombinant leukaemia inhibitory factor
(LIF, 1000 units/ml; Life Technologies) in
gelatinised 96 U-well plates for 6 days. DNA
was extracted from the washed cell sample
adhering to the well by incubating in 10 µl Taq
PCR buffer (Promega), 0.5% Tween 20,
200 µg/ml proteinase K (Sigma) for 1 h at
55°C and 30 min at 90°C before typing by
PCR as described in the legend to Figure 1.
(c) Morphology of typed blastocysts after
6 days in culture. Three examples for each
genotype are shown. (d) Typing of blastocyst
cultures. Half of each of the DNA samples
was used in the multiplex PCR and the
products separated on gel for Southern
blotting as in Figure 1. (e) Phenotypes and
genotypes of blastocysts obtained from
mRev3+/mRev3N heterozygous (and control
mRev+/mRev+ homozygous) intercrosses
after 6 days in culture.
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term but embryonic fibroblasts do not expand and accu-
mulate chromosomal damage [10,11]. 
Thus, perhaps mRev3 (like yeast REV3) plays a role in
the repair of externally induced DNA damage and such
damage might possibly be more heavily inflicted during
in vitro (as opposed to in utero) growth. Alternatively,
mRev3 could play a central role in cell proliferation. This
hypothesis has some attraction in view of the fact that Rev7
(the partner of Rev3 [5,12]) shares a region of homology,
termed the HORMA domain, with Mad2 [6]. Mad2 protein
associates with unattached kinetochores and functions in
the spindle assembly mitotic checkpoint. Furthermore, the
Mad2, Rev3 and Rev7 proteins have been shown to be
capable of interaction in vitro [12]. It may therefore prove
informative to screen for and characterise any genome
damage that accumulates in mRev3-deficient cells.
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